Cleared Traditional

SSS-NX (Serum Substitute Supplement-NX) (K233764) - FDA 510(k) Clearance

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K233764 · Fujifilm Irvine Scientific · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2024
Decision
152d
Days
Class 2
Risk

K233764 is an FDA 510(k) clearance for the SSS-NX (Serum Substitute Supplement-NX). Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by Fujifilm Irvine Scientific (Santa Ana, US). The FDA issued a Cleared decision on April 24, 2024 after a review of 152 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Fujifilm Irvine Scientific devices

Submission Details

510(k) Number K233764 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 24, 2023
Decision Date April 24, 2024
Days to Decision 152 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d faster than avg
Panel avg: 160d · This submission: 152d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQL Media, Reproductive

All 50
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K233764.
Cryo-straw (Type I, Type III)
K233477 · Shandong Wego Ruisheng Medical Device Co., Ltd. · Jul 2024
Giftlife™ Fertilization Medium
K240149 · Gimbo Medical Technology Shenzhen Co., Ltd. · Jun 2024
Oocyte Flushing & Retrieval Medium
K234023 · Gimbo Medical Technology Shenzhen Co., Ltd. · May 2024
V-PVP
K232125 · Vitromed GmbH · Mar 2024
G-Vitri™ Vitrification Freeze Media
K232942 · Gimbo Medical Technology Shenzhen Co., Ltd. · Jan 2024
Dewin Blastocyst Medium (with HSA and without HSA)
K231370 · Donnevie Medical Technology (Shanghai) Co. , Ltd. · Aug 2023